RECORDGATE: unlocking the power of medication records to enable every aspect of digital health & care to be joined-up

处方药是医疗保健领域最常见的干预措施；在英国，它是NHS支出的第二高领域，仅次于员工成本(PSNC，2021)。在政府政策和资金的支持下，通过虚拟病房、数字化社会护理、健康老龄化挑战等倡议，数字化转型和创新在医疗保健领域已变得司空见惯。然而，药品是数字化的重要组成部分，但目前并不存在。例如，远程患者监控平台将自己定位为远程管理患者的“完整”平台，集成了100多台第三方设备--但不包括药品数据。使用数据作为预测工具，预防跌倒是另一个不断增长的领域--这里也没有包括药物数据，尽管药物是跌倒的领先指标。其他这样的例子存在于护理规划空间、长期状况管理和专家护理，例如癌症。之所以出现这种差距，是因为目前这些平台没有正确的数据，其格式可以方便地使用并从中获得洞察力，因此依赖于患者手动输入关于他们的药物的信息--数据通常是缺失、不完整或不准确的，降低了其有用性。这个需求导向的工业研究项目将以协作的方式工作，设计、开发和测试一种新的、改变游戏规则的可互操作药物洞察管道和数据解决方案，以满足这一未得到满足的市场需求--提供前所未有的洞察/情报，可用于先发制人地解决特定于患者的药物相关问题。**以真正可扩展的方式，它将允许为英国任何拥有NHS编号的患者提供丰富的、与背景相关的药物洞察，打开一个巨大的市场机会。**该项目将把药物置于正在进行的医疗和护理数字化转型的核心，结束护理人员、临床医生和他们的患者之间的循环。

Prescribed medicines are the most common intervention in healthcare; in the UK, it is the second highest area of NHS spending, after staff costs (PSNC, 2021).Digital transformation and innovation have become commonplace in health and care, backed by government policy and funding, through initiatives such as Virtual Wards, Digitising Social Care, Healthy Ageing Challenge, among others. However, medicines are an essential but currently absent part of this digitisation. For example, remote patient monitoring platforms position themselves as 'complete' platforms to manage patients remotely, integrating with over 100+ third-party devices -- medicines data, however, is not included. Falls prevention is another growing space using data as as a predictive tool -- here too, medicines data, is not included despite medicines being a leading indicator for falls. Other such examples exist in the care planning space, long-term condition management, and specialist care e.g. cancer.This gap has arisen because currently these platforms do not have the right data available in a format that they can easily use and draw insights from and are, therefore, reliant on patients manually inputting their information about their medicines -- data, which is often missing, incomplete or inaccurate, reducing its usefulness.Working in a collaborative approach, this demand-led industrial research project will design, develop, and test a novel, game-changing interoperable medicines insights pipeline and data solution to address this unmet market need -- delivering unprecedented insights/intelligence that can be used to pre-empt medicines-related issues _specific to the patient_.**In a truly scalable manner, it will allow rich and contextualised medicines insights to be provided for any patient in the UK with an NHS number, opening up a huge market opportunity.**This project will place medicines at the heart of the ongoing digital transformation of health and care, closing the loop between carers, clinicians, and their patients.